The purpose of France’s Health Data Hub (HDH) is to facilitate the sharing of health data to support research and innovation. Launched in December 2019, the HDH is a health data platform established by the French government to combine existing health databases and make them more accessible for research and development purposes [1].
The platform allows public interest project leaders to access large volumes of data and utilize the platform’s computing power to run complex research algorithms [2].
The reuse of health data has significant potential for enhancing healthcare quality and patient support through research. This includes [3]:
- Evaluating the effectiveness of treatments for rare pathologies like sarcoma by combining patient and insurance data.
- Enhancing prescription alert systems to help healthcare professionals make better decisions in complex clinical scenarios.
- Developing early warning tools for conditions like heart failure by correlating pacemaker and hospitalization data.
- Predicting disease progression, as in Parkinson’s disease, and improving preventive measures using patient cohort data.
- Streamlining the reporting and analysis of adverse drug reactions to improve healthcare system transparency.
- Utilizing AI to improve early cancer screening, thus reducing false positives and negatives, and saving medical time.
- Gathering data on long-term effects of medications, particularly in cases of organ transplantation, to optimize therapeutic strategies.
Researchers interested in accessing real-world data (RWD) and generating real-world evidence (RWE) can benefit from the HDH in several ways:
- Data Accessibility: The HDH provides a single gateway for health data in France, making it easier for researchers to access various data sources [4].
- Data Catalogue: The platform includes a data catalogue with one of the world’s largest healthcare claims databases, offering researchers a rich source of information for their studies [4].
- Collaboration: The HDH brings together 56 stakeholders, including the largest French public organization for scientific research, CNRS, fostering collaboration between government, producers of health data, and users of public and private health data [1].
- Support for Projects: The HDH provides researchers with the necessary resources and infrastructure to carry out their studies [4].
- Data Security: The platform ensures the protection of health data through a data access approval process, maintaining the privacy and security of sensitive information [4].
By providing researchers with easier access to health data and the necessary resources to analyse and process this data, the HDH can help generate valuable insights and contribute to advancements in the health sector [4].
References:
[1] Everything you need to know about Health Data Hub – Implicity
Link: https://www.implicity.com/everything-you-need-to-know-about-health-data-hub/
[2] The Health Data Hub publishes its roadmap for 2022 – French Healthcare (30 May 2022)
Link: https://frenchhealthcare.fr/the-health-data-hub-publishes-its-roadmap-for-2022/
[3] Health Data Hub – FAQ in English
Link: https://www.health-data-hub.fr/page/faq-english
[4] Health Data Hub – Multi-stakeholder workshop RWD quality and RWE use (26 June 2023)
Share this story...
Lithuania – Leaping into Digital Health Future with RWE and RWD Innovations
RWE 201 - Lithuania – Leaping into Digital Health Future with RWE and RWD Innovations EU Partnership Agreement: https://ec.europa.eu/commission/presscorner/detail/en/ip_22_2547Lithuania is actively implementing Real-World Evidence (RWE) and Real-World Data (RWD) [...]
RWE Guest Post – Does Real-World Evidence Play a Role in G-BA’s Benefit Assessments in Germany?
RWE 201 - RWE Guest Post - Does real-world evidence play a role in G-BA's benefit assessments in Germany? Guest: Anja PownellGerman Market Access – Simplified: https://germanmarketaccesssimplified.com/IntroductionThe German [...]
RWE Guest Post – Germany – From Concept to Evaluation: The Journey of RWE requests by the G-BA
RWE 201 - RWE Guest Post – Germany - From Concept to Evaluation: The Journey of RWE requests by the G-BA Guest: Anja PownellGerman Market Access – Simplified: [...]
Spain – Championing the Ethical and Responsible Use of Real World Data
RWE 201 - Spain – Championing the Ethical and Responsible Use of Real World Data Farmindustria Code of Conduct: https://codigoprotecciondatos.farmaindustria.org/sites/medicamentosinnovadores/docs/PRODF484450.pdfIn 2022, the Spanish Data Protection Agency (AEPD) gave its [...]
EU – RWD/RWE is Embedded into the New EU Medicines Regulations
RWE 201 - EU – RWD/RWE is Embedded into the New EU Medicines Regulations Coming Soon…New EU Medicines Regulations: https://health.ec.europa.eu/medicinal-products/pharmaceutical-strategy-europe/reform-eu-pharmaceutical-legislation_enIn 2023, the European Commission undertook an ambitious overhaul of [...]
EU – EU’s Action Plan for Real-World Data (RWD) & RWE
RWE 201 - EU – EU's Action Plan for Real-World Data (RWD) & RWE The European Union has embarked on an ambitious journey to weave Real World Evidence (RWE) [...]







